Interestingly, most of the relationships between drug resistance and the expression levels of the up-UDEGs ANLN, GPRC5A and SERPINB5 were positive (Figure 4B), indicating that these three genes are closely related to the resistance mechanisms of pancreatic cancer. This evidence concerns the gene ANLN and familial pancreatic carcinoma.